Frontotemporal dementia: insights into the biological underpinnings of disease through gene co-expression network analysis

BackgroundIn frontotemporal dementia (FTD) there is a critical lack in the understanding of biological and molecular mechanisms involved in disease pathogenesis. The heterogeneous genetic features associated with FTD suggest that multiple disease-mechanisms are likely to contribute to the development of this neurodegenerative condition.We here present a systems biology approach with the scope of i) shedding light on the biological processes potentially implicated in the pathogenesis of FTD and ii) identifying novel potential risk factors for FTD. We performed a gene co-expression network analysis of microarray expression data from 101 individuals without neurodegenerative diseases to explore regional-specific co-expression patterns in the frontal and temporal cortices for 12 genes (MAPT, GRN, CHMP2B, CTSC, HLA-DRA, TMEM106B, C9orf72, VCP, UBQLN2, OPTN, TARDBP and FUS) associated with FTD and we then carried out gene set enrichment and pathway analyses, and investigated known protein-protein interactors (PPIs) of FTD-genes products.ResultsGene co-expression networks revealed that several FTD-genes (such as MAPT and GRN, CTSC and HLA-DRA, TMEM106B, and C9orf72, VCP, UBQLN2 and OPTN) were clustering in modules of relevance in the frontal and temporal cortices. Functional annotation and pathway analyses of such modules indicated enrichment for: i) DNA metabolism, i.e. transcription regulation, DNA protection and chromatin remodelling (MAPT and GRN modules); ii) immune and lysosomal processes (CTSC and HLA-DRA modules), and; iii) protein meta/catabolism (C9orf72, VCP, UBQLN2 and OPTN, and TMEM106B modules). PPI analysis supported the results of the functional annotation and pathway analyses.ConclusionsThis work further characterizes known FTD-genes and elaborates on their biological relevance to disease: not only do we indicate likely impacted regional-specific biological processes driven by FTD-genes containing modules, but also do we suggest novel potential risk factors among the FTD-genes interactors as targets for further mechanistic characterization in hypothesis driven cell biology work.

[1]  B. Charroux,et al.  Neurodegeneration by polyglutamine Atrophin is not rescued by induction of autophagy , 2010, Cell Death and Differentiation.

[2]  Colin Smith,et al.  Tissue and organ donation for research in forensic pathology: the MRC Sudden Death Brain and Tissue Bank , 2007, The Journal of pathology.

[3]  P. Newburger,et al.  Regulation of CYBB Gene Expression in Human Phagocytes by a Distant Upstream NF‐κB Binding Site , 2015, Journal of cellular biochemistry.

[4]  W. Zwart,et al.  Spatial separation of HLA-DM/HLA-DR interactions within MIIC and phagosome-induced immune escape. , 2005, Immunity.

[5]  Stephanie Schorge,et al.  Insights from cerebellar transcriptomic analysis into the pathogenesis of ataxia. , 2014, JAMA neurology.

[6]  N. Cairns,et al.  Mechanisms of disease in frontotemporal lobar degeneration: gain of function versus loss of function effects , 2012, Acta Neuropathologica.

[7]  F. Jessen,et al.  A Pan-European Study of the C9orf72 Repeat Associated with FTLD: Geographic Prevalence, Genomic Instability, and Intermediate Repeats , 2012, Human mutation.

[8]  J R Hodges,et al.  The prevalence of frontotemporal dementia , 2002, Neurology.

[9]  J. Leek,et al.  Temporal dynamics and genetic control of transcription in the human prefrontal cortex , 2011, Nature.

[10]  R. Saul,et al.  Dedicator of cytokinesis 8 is disrupted in two patients with mental retardation and developmental disabilities. , 2008, Genomics.

[11]  S. Horvath,et al.  Divergence of human and mouse brain transcriptome highlights Alzheimer disease pathways , 2010, Proceedings of the National Academy of Sciences.

[12]  N. Mantel The detection of disease clustering and a generalized regression approach. , 1967, Cancer research.

[13]  Alexander Gerhard,et al.  Frontotemporal dementia and its subtypes: a genome-wide association study , 2014, The Lancet Neurology.

[14]  Madoka Inuzuka,et al.  Serinc, an Activity-regulated Protein Family, Incorporates Serine into Membrane Lipid Synthesis* , 2005, Journal of Biological Chemistry.

[15]  angesichts der Corona-Pandemie,et al.  UPDATE , 1973, The Lancet.

[16]  Joel H Kramer,et al.  Anatomical correlates of reward-seeking behaviours in behavioural variant frontotemporal dementia. , 2014, Brain : a journal of neurology.

[17]  H. Sarnat,et al.  Infantile tauopathies: Hemimegalencephaly; tuberous sclerosis complex; focal cortical dysplasia 2; ganglioglioma , 2015, Brain and Development.

[18]  I. Shachar,et al.  CD74 (CD74 molecule, major histocompatibility complex, class II invariant chain) , 2014 .

[19]  J. Hodges,et al.  Longitudinal white matter changes in frontotemporal dementia subtypes , 2014, Human brain mapping.

[20]  M. Blackledge,et al.  Phosphorylation of human Tau protein by microtubule affinity-regulating kinase 2. , 2013, Biochemistry.

[21]  L. Buée,et al.  A major role for Tau in neuronal DNA and RNA protection in vivo under physiological and hyperthermic conditions , 2014, Front. Cell. Neurosci..

[22]  Zhenjun Hu,et al.  Using VisANT to Analyze Networks , 2014, Current protocols in bioinformatics.

[23]  Nick C Fox,et al.  White matter tract signatures of the progressive aphasias , 2013, Neurobiology of Aging.

[24]  Rui Luo,et al.  Is My Network Module Preserved and Reproducible? , 2011, PLoS Comput. Biol..

[25]  M. J. Fresnadillo Martínez,et al.  Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions , 2010, Nature Genetics.

[26]  M. Matsuda,et al.  Role of Crk oncogene product in physiologic signaling. , 1997, Critical reviews in oncogenesis.

[27]  Miro Brajenovic,et al.  MARK4 Is a Novel Microtubule-associated Proteins/Microtubule Affinity-regulating Kinase That Binds to the Cellular Microtubule Network and to Centrosomes* , 2004, Journal of Biological Chemistry.

[28]  S. Nelson,et al.  Molecular taxonomy of major neuronal classes in the adult mouse forebrain , 2006, Nature Neuroscience.

[29]  Li-chuan,et al.  Molecular Neurodegeneration , 2017 .

[30]  Steve Horvath,et al.  Molecular Systems Biology 5; Article number 291; doi:10.1038/msb.2009.46 Citation: Molecular Systems Biology 5:291 , 2022 .

[31]  Nick C Fox,et al.  Profiles of white matter tract pathology in frontotemporal dementia , 2014, Human brain mapping.

[32]  Daniel R. Salomon,et al.  Strategies for aggregating gene expression data: The collapseRows R function , 2011, BMC Bioinformatics.

[33]  B. Bogerts,et al.  Nardilysin in human brain diseases: both friend and foe , 2013, Amino Acids.

[34]  A. Ramasamy,et al.  Quality control parameters on a large dataset of regionally dissected human control brains for whole genome expression studies , 2011, Journal of neurochemistry.

[35]  Expression of SGTA correlates with neuronal apoptosis and reactive gliosis after spinal cord injury , 2014, Cell and Tissue Research.

[36]  S. Horvath,et al.  Functional organization of the transcriptome in human brain , 2008, Nature Neuroscience.

[37]  J. Toth,et al.  CAND1 controls in vivo dynamics of the Cullin 1-RING ubiquitin ligase repertoire , 2013, Nature Communications.

[38]  Frederik Barkhof,et al.  More atrophy of deep gray matter structures in frontotemporal dementia compared to Alzheimer's disease. , 2015, Journal of Alzheimer's disease : JAD.

[39]  Michel Goedert,et al.  Tau pathology and neurodegeneration , 2013, The Lancet Neurology.

[40]  P. Momeni,et al.  Molecular Genetics of Frontotemporal Dementia , 2013 .

[41]  Masaaki Komatsu,et al.  Autophagy and Neurodegeneration , 2006, Autophagy.

[42]  J. Rohrer,et al.  Phenotypic signatures of genetic frontotemporal dementia. , 2011, Current opinion in neurology.

[43]  J. Hardy,et al.  Motor neuron disease and frontotemporal dementia: sometimes related, sometimes not , 2014, Experimental Neurology.

[44]  L. Buée,et al.  Nuclear Tau, a Key Player in Neuronal DNA Protection* , 2010, The Journal of Biological Chemistry.

[45]  S. Brady Mice overexpressing the human neurofilament heavy gene as a model of ALS , 1995, Neurobiology of Aging.

[46]  Carlos Cruchaga,et al.  TMEM106B: a strong FTLD disease modifier , 2014, Acta Neuropathologica.

[47]  S. Amor,et al.  Innate and adaptive immune responses in neurodegeneration and repair , 2014, Immunology.

[48]  S. Horvath,et al.  Statistical Applications in Genetics and Molecular Biology , 2011 .

[49]  Nick C Fox,et al.  Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features , 2012, Alzheimer's & Dementia.

[50]  R. Zinkowski,et al.  Presence of tau in isolated nuclei from human brain , 1995, Neurobiology of Aging.

[51]  Jennifer M. Pocock,et al.  Insights into TREM2 biology by network analysis of human brain gene expression data , 2013, Neurobiology of Aging.

[52]  Jaak Vilo,et al.  g:Profiler—a web server for functional interpretation of gene lists (2011 update) , 2011, Nucleic Acids Res..

[53]  A. Gade,et al.  Frontotemporal Dementia Linked to Chromosome 3 , 2004, Dementia and Geriatric Cognitive Disorders.

[54]  R. Faber,et al.  Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. , 1999, Neurology.

[55]  Steve Horvath,et al.  WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.

[56]  Lei Wang,et al.  Atrophin proteins: an overview of a new class of nuclear receptor corepressors , 2008, Nuclear Receptor Signaling.

[57]  Y. Xing,et al.  A Transcriptome Database for Astrocytes, Neurons, and Oligodendrocytes: A New Resource for Understanding Brain Development and Function , 2008, The Journal of Neuroscience.

[58]  D. Cleveland,et al.  Converging Mechanisms in ALS and FTD: Disrupted RNA and Protein Homeostasis , 2013, Neuron.